Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03857815
What this trial is testing

Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04507217
What this trial is testing

Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC

Who this might be right for
NSCLC Stage IVBrain MetastasesPD-1 Antibody
Sun Yat-sen University 36
Early research (Phase 1)Active Not RecruitingNCT03816358
What this trial is testing

Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 74
Large-scale testing (Phase 3)WithdrawnNCT03791918
What this trial is testing

Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)UnknownNCT03615313
What this trial is testing

PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Shanghai Cell Therapy Research Institute 50
Early research (Phase 1)Not Yet RecruitingNCT07637786
What this trial is testing

Peptide Nanovaccine (ONVAX-01) Plus Anti-PD-1 Antibody and Chemotherapy in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Adenocarcinoma
Sichuan University 9
Testing effectiveness (Phase 2)WithdrawnNCT03501056
What this trial is testing

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer

Who this might be right for
Advanced Lung Cancer
Fuda Cancer Hospital, Guangzhou
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06790212
What this trial is testing

Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer
Sun Yat-sen University 168
Testing effectiveness (Phase 2)Ended earlyNCT05161572
What this trial is testing

Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer

Who this might be right for
Stomach NeoplasmsEsophagogastric Junction DisorderNeoadjuvant Therapy+5 more
Fudan University 6
Testing effectiveness (Phase 2)Study completedNCT01714739
What this trial is testing

An Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors

Who this might be right for
CANCER,NOS
Bristol-Myers Squibb 337
Early research (Phase 1)Looking for participantsNCT06773481
What this trial is testing

BC008-1A Injection for Recurrent CNS WHO G4 Glioma

Who this might be right for
GliomaGlioma Tumor RecurrenceGlioma, Recurrent High Grade+2 more
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07277439
What this trial is testing

Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma

Who this might be right for
Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University 48
Large-scale testing (Phase 3)Study completedNCT03430843
What this trial is testing

Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
BeiGene 512
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06781125
What this trial is testing

One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors

Who this might be right for
Malignant Solid Tumors
Immorna Biotherapeutics, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT05199753
What this trial is testing

Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumor
LaNova Australia Pty Limited 78
Testing effectiveness (Phase 2)Looking for participantsNCT07637448
What this trial is testing

EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC

Who this might be right for
Lung Cancer Non-Small Cell Cancer (NSCLC)EGFR Activating MutationPD-1 Antibody
Nanfang Hospital, Southern Medical University 32
Large-scale testing (Phase 3)UnknownNCT03707509
What this trial is testing

Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 263
Testing effectiveness (Phase 2)UnknownNCT05979740
What this trial is testing

RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC

Who this might be right for
Muscle Invasive Bladder CancerHER2 ExpressionRadiotherapy+2 more
RenJi Hospital 6
Testing effectiveness (Phase 2)Study completedNCT02760498
What this trial is testing

Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma

Who this might be right for
Advanced Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals 432
Early research (Phase 1)UnknownNCT03393416
What this trial is testing

A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor

Who this might be right for
Advanced Gastric Cancer
HRYZ Biotech Co. 28
Next Page